EGF and breast carcinoma: For the ER-positive human breast cancer cell line, the ganglioside content of MCF-7 cells was reported to be higher than MDA-MB-231 cells and membrane-inserted ganglioside GM3 of MCF-7 cells blocked EGF-stimulated growth [24].